Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.748 SEK | -0.90% | -2.78% | -3.60% |
Sales 2023 | 9M 842K | Sales 2024 * | 26.75M 2.5M | Capitalization | 311M 29.08M |
---|---|---|---|---|---|
Net income 2023 | -89M -8.33M | Net income 2024 * | -96M -8.99M | EV / Sales 2023 | -1.16 x |
Net cash position 2023 | 170M 15.88M | Net cash position 2024 * | 94.7M 8.86M | EV / Sales 2024 * | 8.07 x |
P/E ratio 2023 |
-1.93
x | P/E ratio 2024 * |
-3.06
x | Employees | 10 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.19% |
Latest transcript on Medivir AB
1 day | -2.40% | ||
1 week | -2.74% | ||
Current month | -11.61% | ||
1 month | -14.91% | ||
3 months | -3.22% | ||
6 months | -61.26% | ||
Current year | -3.56% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.748 | -0.90% | 843 740 |
24-03-27 | 2.772 | -2.33% | 144,328 |
24-03-26 | 2.838 | +3.37% | 507,195 |
24-03-25 | 2.746 | +0.59% | 87,131 |
24-03-22 | 2.73 | -3.40% | 106,199 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:26 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.56% | 29.25M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.95% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |